Zfp462 Is a Key Mediator of Osteoblast Differentiation and Might Contribute to Age‐Related Bone Loss
Aging Cell · 2026-04 · 25 (4)
DOI: 10.1111/acel.70476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 16.04.2026. Verfasst von Jin-Man Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Asan Medical Center, Asan Institute for Life Sciences, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Osteoblasts, Cell Differentiation, Osteoporosis, Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Senile osteoporosis is characterized by a progressive decline in bone formation. Our study identifies Zfp462/ZNF462 as a novel regulator of osteoblast differentiation, providing new mechanistic insights into the aging‐related change in bone formation. Here, we demonstrate that ZNF462, MOZ, and RUNX2 physically interact with each other and promote osteoblastic bone formation by increasing RUNX2 activity and histone H3 acetylation. Importantly, we reveal that aging decreases ZNF462 expression in bone cells, a process linked to reduced occupancy of the histone variant H2A.Z at the ZNF462 locus, leading to lower transcriptional activator histone H3K4 trimethylation. The osteoblast‐specific Zfp462 deficiency in mice results in decreased bone mass and strength, primarily due to impaired osteoblast function. By uncovering a previously unknown ZNF462‐MOZ‐RUNX2 axis, this work provides a molecular basis for understanding the development of senile osteoporosis. Thus, targeting ZNF462 or MOZ could offer a new strategy to restore bone formation in aging populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Asan Medical Center, Asan Institute for Life Sciences, Seoul, Republic of Korea.
- AMIST, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Molecular Medicine, CMRI, School of Medicine, Kyungpook National, University, Daegu, Republic of Korea.
- Convergence Medicine Research Center, Asan Institute for Life Sciences, Seoul, Republic of Korea.
- Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Jung-Eun Kim
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
Zitieren
APA
Kim, J. M., Kim, H. K., Moon, S. A., Kim, Y., Lee, S. H., Yu, J., Lee, S. H., Son, W. C., Kim, J. E., Baek, I. J., Kim, Y. B., & Koh, J. M. (2026). Zfp462 Is a Key Mediator of Osteoblast Differentiation and Might Contribute to Age‐Related Bone Loss. Aging Cell, 25(4). https://doi.org/10.1111/acel.70476
Vancouver
Kim JM, Kim HK, Moon SA, Kim Y, Lee SH, Yu J, et al. Zfp462 Is a Key Mediator of Osteoblast Differentiation and Might Contribute to Age‐Related Bone Loss. Aging Cell. 2026;25(4). doi:10.1111/acel.70476
BibTeX
@article{Kim2026,
author = {Kim, Jin-Man and Kim, Ho Kyoung and Moon, Sung-Ah and Kim, Yewon and Lee, Seung-Hoon and Yu, Jiyoung and Lee, Seung Hun and Son, Woo Chan and Kim, Jung-Eun and Baek, In-Jeoung and Kim, Young-Bum and Koh, Jung-Min},
title = {Zfp462 Is a Key Mediator of Osteoblast Differentiation and Might Contribute to Age‐Related Bone Loss},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/acel.70476}
}
EUVIMED